LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Medical Questions » RE: info on quinolones & cat's claw

 - UBBFriend: Email this page to someone!    
Author Topic: RE: info on quinolones & cat's claw
ArtistDi
Frequent Contributor (1K+ posts)
Member # 2297

Icon 1 posted      Profile for ArtistDi     Send New Private Message       Edit/Delete Post   Reply With Quote 
From another patient's experience--

"I did want to pass on something that happened to me. I reacted to
cipro > (fluoroquinolone antibiotic) last spring with severe
shoulder tendon pain. > You warned me about the dangers of this
family of antibiotics. Well, I had > the same reaction when I tried
the cat's claw herb (Samento and Prima Una de > Gato) that is being
used for Lyme disease. It was SEVERE tendon pain again.
> I researched it and found that quinovic acid glycosides are the
basis for > cat's claw AND the synthetic quinolones!! SO, no more of
that herb for me!!
> Tendon damage and rupture are not things I want to mess with. Just
thought I > should let you know about this. Get well." [end of quote]

Eur J Pharmacol. 2002 May 24;444(1-2):39-45.

Pteropodine and isopteropodine positively modulate the function of
rat muscarinic M(1) and 5-HT(2) receptors expressed in Xenopus oocyte.

Kang TH, Matsumoto K, Tohda M, Murakami Y, Takayama H, Kitajima M,
Aimi N, Watanabe H.

Department of Pharmacology, Institute of Natural Medicine, Toyama
Medical and Pharmaceutical University, 2630 Sugitani, Toyama, 930-
0194, Japan.

Pteropodine and isopteropodine are heteroyohimbine-type oxindole
alkaloid components of Uncaria tomentosa (Willd.) DC, a Peruvian
medicinal plant known as cat's claw. In this study, the effects of
these alkaloids on the function of Ca(2+)-activated Cl(-) currents
evoked by stimulation of G protein-coupled muscarinic M(1)
acetylcholine and 5-HT(2) receptors were studied in Xenopus oocytes
in which rat cortex total RNA was translated. Pteropodine and
isopteropodine (1-30 microM) failed to induce membrane current by
themselves. However, these alkaloids markedly enhanced the current
responses evoked by both acetylcholine and 5-hydroxyhyptamine (5-HT)
in a concentration-dependent and reversible manner with the maximal
effects at 30 microM. Pteropodine and isopteropodine produced 2.7-
and 3.3-fold increases in the acetylcholine response with EC(50)
values of 9.52 and 9.92 microM, respectively, and 2.4- and 2.5-fold
increases in the 5-HT response with EC(50) values of 13.5 and 14.5
microM, respectively. In contrast, in oocytes injected with total RNA
from the rat cerebellum or spinal cord, neither alkaloid had an
effect on the metabotropic current responses mediated by glutamate
receptor(1 and 5) (mGlu(1/5)) receptors or ionotropic responses
mediated by N-methyl-D-aspartate, kainic acid or glycine. Pteropodine
and isopteropodine (10 microM) significantly reduced the EC(50)
values of acetylcholine and 5-HT that elicited current responses, but
had no effect on the maximal current responses elicited by
acetylcholine and 5-HT. On the other hand, mitraphylline, a
stereoisomer of pteropodine, failed to modulate acetylcholine- and 5-
HT-induced responses. These results suggest that pteropodine and
isopteropodine act as positive modulators of muscarinic M(1) and 5-HT
(2) receptors.

PMID: 12191580 [PubMed - indexed for MEDLINE]

Clin Exp Pharmacol Physiol. 1996 May;23(5):355-62. Related Articles,
Links


Action of cholinesters on sensory nerve endings in skin and muscle.

Carr RW, Proske U.

Department of Physiology, Monash University, Clayton, Victoria,
Australia.

1. This is a review of the literature on the subject of the effects
of cholinesters and their agonists on sensory nerve endings. 2. The
present-day view is that acetylcholine (ACh) has an excitatory action
on some cutaneous receptors. Responses appear to be limited to
receptors served by small myelinated and un-myelinated axons where
responsiveness is multimodal; that is, the receptors are activated by
noxious thermal and mechanical stimulation. 3. The possible role
played by acetylcholine in sensory transduction processes is
discussed, as are other explanations for the presence of nicotinic
cholinergic receptors on the terminals of cutaneous receptors. 4. The
excitatory action of ACh and succinylcholine (SCh) on muscle spindles
is described. Two possible mechanisms are considered: a direct
depolarizing action on the nerve terminals and indirect excitation,
brought about by a contracture of the intrafusal fibres on which the
sensory endings lie. 5. The technique of using SCh in combination
with fusimotor stimulation is described. This has provided new
information about the internal workings of muscle spindles. Brief
mention is also made of the action of SCh on tendon organs and joint
receptors. 6. It is concluded that a direct action by cholinesters is
restricted to receptors served by small axons with multimodal
functions. The precise role of such an action remains the subject of
speculation. Possible clinical significance is discussed.

Publication Types:
Review
Review, Tutorial

PMID: 8713671 [PubMed - indexed for MEDLINE]





Perhaps of some use.

Toxicol Rev. 2005;24(1):11-35. Related Articles, Links


Toxicological aspects of the South American herbs cat's claw (Uncaria tomentosa) and Maca (Lepidium meyenii) : a critical synopsis.

Valerio LG Jr, Gonzales GF.

Division of Biotechnology and GRAS Notice Review, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland 20740, USA. [email protected]

Recent exceptional growth in human exposure to natural products known to originate from traditional medicine has lead to a resurgence of scientific interest in their biological effects. As a strategy for improvement of the assessment of their pharmacological and toxicological profile, scientific evidence-based approaches are being employed to appropriately evaluate composition, quality, potential medicinal activity and safety of these natural products. Using this approach, we comprehensively reviewed existing scientific evidence for known composition, medicinal uses (past and present), and documented biological effects with emphasis on clinical pharmacology and toxicology of two commonly used medicinal plants from South America with substantial human exposure from historical and current global use: Uncaria tomentosa (common name: cat's claw, and Spanish: una de gato), and Lepidium meyenii (common name: maca). Despite the geographic sourcing from remote regions of the tropical Amazon and high altitude Andean mountains, cat's claw and maca are widely available commercially in industrialised countries. Analytical characterisations of their active constituents have identified a variety of classes of compounds of toxicological, pharmacological and even nutritional interest including oxindole and indole alkaloids, flavonoids, glucosinolates, sterols, polyunsaturated fatty acids, carbolines and other compounds.The oxindole alkaloids from the root bark of cat's claw are thought to invoke its most widely sought-after medicinal effects as a herbal remedy against inflammation. We find the scientific evidence supporting this claim is not conclusive and although there exists a base of information addressing this medicinal use, it is limited in scope with some evidence accumulated from in vitro studies towards understanding possible mechanisms of action by specific oxindole alkaloids through inhibition of nuclear factor (NF)-kappaB activation. Although controlled clinical studies have demonstrated reduction in pain associated with cat's claw intake in patients with various chronic inflammatory disorders, there is insufficient clinical data overall to draw a firm conclusion for its anti-inflammatory effects. An important observation was that experimental results were often dependent upon the nature of the preparation used. It appears that the presence of unknown substances has an important role in the overall effects of cat's claw extracts is an important factor for consideration. The available animal toxicological studies did not indicate severe toxicity from oral intake of cat's claw preparations but rather were suggestive of a low potential for acute and subacute oral toxicity, and a lack of evidence to demonstrate genotoxic potential and mutagenic activity.Maca is a clear example of a herb with substantial medicinal use in traditional herbal medicine by indigenous cultures in South America since the first recorded knowledge of it in the seventeenth century. The hypocotyls of maca are the edible part of the plant used for nutritional and proposed fertility-enhancing properties. Maca has been described to possess many other medicinal properties in traditional herbal medicine but only a few of them have been well studied scientifically. Published clinical studies of maca seem to be related to its property as a nutrient, for male fertility and for energy. There are inadequate data regarding the precise mechanism of action of maca. Some studies suggest that secondary metabolites found in maca extracts are important constituents responsible for its physiological effects. Maca has been reported in the scientific literature to have a low degree of acute oral toxicity in animals and low cellular toxicity in vitro.An important finding unveiled by this review is the importance of standardisation in quality and additional basic and clinical research to scientifically validate and understand composition, biological activity, safety and risk. Development of a comprehensive pharmacological and toxicological profile through critical evaluation of existing and future experimental data, especially carefully conducted clinical studies would facilitate the scientific evidence-based approach to understanding potential biological effects of these major traditionally based herbals in current global use.

Publication Types:
Review

PMID: 16042502 [PubMed - indexed for MEDLINE]

Posts: 1572 | From Hatfield, MA, USA | Registered: Mar 2002  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.